Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -40.51% is in line with its 5-year average of -39.04%, around the middle of its 5-year range (-93.42%–-13.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.06% below its 12-month average of -36.81%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -40.51%.
RETURN ON INVESTED CAPITAL (ROIC)
-40.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-36.81%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-47.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-39.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-45.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-63.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-10.06%
CURRENT VS 3Y AVG
+14.22%
CURRENT VS 5Y AVG
-3.79%
CURRENT VS 10Y AVG
+10.92%
CURRENT VS 15Y AVG
+36.11%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 747 covered companies
CURRENT VS SECTOR MEDIAN
-20.11%
vs the sector median at left
ClearPoint Neuro, Inc.
Market Cap
$322.99M
Return on Invested Capital (ROIC)
-40.51%
TTM Avg
-36.81%
3Y Avg
-47.23%
5Y Avg
-39.04%
Market Cap
$324.22M
Return on Invested Capital (ROIC)
-136.92%
TTM Avg
-105.47%
3Y Avg
-71.42%
5Y Avg
-55.10%
Market Cap
$324.01M
Return on Invested Capital (ROIC)
-164.32%
TTM Avg
-159.25%
3Y Avg
-125.06%
5Y Avg
-125.06%
Market Cap
$324.15M
Return on Invested Capital (ROIC)
-85.56%
TTM Avg
-114.55%
3Y Avg
-77.72%
5Y Avg
-63.50%
Market Cap
$321.67M
Return on Invested Capital (ROIC)
18.15%
TTM Avg
3.75%
3Y Avg
-6.35%
5Y Avg
-21.63%
Market Cap
$330.11M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-35.18%
3Y Avg
-129.73%
5Y Avg
-103.61%
Market Cap
$315.67M
Return on Invested Capital (ROIC)
-35.92%
TTM Avg
-35.67%
3Y Avg
-36.59%
5Y Avg
-30.23%
Market Cap
$306.26M
Return on Invested Capital (ROIC)
-122.21%
TTM Avg
-122.21%
3Y Avg
-122.21%
5Y Avg
-122.21%
Market Cap
$300.75M
Return on Invested Capital (ROIC)
-28.88%
TTM Avg
-35.80%
3Y Avg
-1011.32%
5Y Avg
-772.02%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ClearPoint Neuro, Inc. (CLPT) | $322.99M | -40.51% | -36.81% | -47.23% | -39.04% |
| Avita Medical Inc. (RCEL)vs › | $324.22M | -136.92% | -105.47% | -71.42% | -55.10% |
| CapsoVision, Inc. (CV)vs › | $324.01M | -164.32% | -159.25% | -125.06% | -125.06% |
| Cabaletta Bio, Inc. (CABA)vs › | $324.15M | -85.56% | -114.55% | -77.72% | -63.50% |
| Sanara MedTech Inc. (SMTI)vs › | $321.67M | 18.15% | 3.75% | -6.35% | -21.63% |
| Agenus Inc. (AGEN)vs › | $330.11M | N/A | -35.18% | -129.73% | -103.61% |
| C4 Therapeutics, Inc. (CCCC)vs › | $315.67M | -35.92% | -35.67% | -36.59% | -30.23% |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $306.26M | -122.21% | -122.21% | -122.21% | -122.21% |
| Benitec Biopharma Inc. (BNTC)vs › | $300.75M | -28.88% | -35.80% | -1011.32% | -772.02% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $294.51M | -136.49% | -130.82% | -85.38% | -76.42% |
ROIC
-40.5%
ROE
-320.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -40.51% |
| 2026-03-31 | -31.55% |
| 2025-12-31 | -27.78% |
| 2025-09-30 | -43.44% |
| 2025-06-30 | -40.78% |
| 2025-03-31 | -93.42% |
| 2024-12-31 | -68.48% |
| 2024-09-30 | -57.75% |
| 2024-06-30 | -40.50% |
| 2024-03-31 | -43.28% |
| 2023-12-31 | -63.71% |
| 2023-09-30 | -58.07% |
| 2023-06-30 | -50.94% |
| 2023-03-31 | -41.14% |
| 2022-12-31 | -33.53% |
| 2022-09-30 | -30.68% |
| 2022-06-30 | -28.95% |
| 2022-03-31 | -26.05% |
| 2021-12-31 | -21.99% |
| 2021-09-30 | -18.18% |
| 2021-06-30 | -13.43% |
| 2021-03-31 | -10.11% |
| 2020-12-31 | -23.64% |
| 2020-09-30 | -29.51% |
| 2020-06-30 | -25.70% |
| 2020-03-31 | -24.22% |
| 2019-12-31 | -56.75% |
| 2019-09-30 | -45.61% |
| 2019-06-30 | -44.42% |
| 2019-03-31 | -89.57% |
| 2018-12-31 | -89.73% |
| 2018-09-30 | -91.63% |
| 2018-06-30 | -65.13% |
| 2018-03-31 | -60.52% |
| 2017-12-31 | -55.10% |
| 2017-09-30 | -49.14% |
| 2017-06-30 | -47.95% |
| 2017-03-31 | -233.03% |
| 2016-12-31 | -170.85% |
| 2016-09-30 | -126.61% |
| 2016-06-30 | -261.73% |
| 2016-03-31 | -157.32% |
| 2015-12-31 | -134.46% |
| 2015-09-30 | -379.18% |
| 2015-06-30 | -437.16% |
| 2015-03-31 | -204.23% |
| 2014-12-31 | -62.84% |
| 2014-09-30 | -1005.87% |
| 2014-06-30 | -106.21% |
| 2014-03-31 | -79.38% |
| 2013-12-31 | -352.41% |
| 2013-09-30 | -183.52% |
| 2013-06-30 | -85.86% |
| 2013-03-31 | -49.67% |
| 2012-12-31 | -228.12% |
| 2012-09-30 | -316.54% |
